<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.8: Building a Custom Testing Roadmap for Clients</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Advanced Testing */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            margin-top: 40px;
            font-size: 14px;
            border: 1px solid #e5e7eb;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Advanced Testing & Biomarker Analysis</p>
            <h1 class="lesson-title">Lesson 12.8: Building a Custom Testing Roadmap for Clients</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 8 of 10</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Hierarchy of Testing</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Phase 1: Antigen Mapping</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Phase 2: Regulatory Assessment</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Phase 3: Mucosal & Barrier Integrity</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Testing Frequency & Remission Maintenance</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Cost-Benefit Analysis in Testing</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the sequential hierarchy of testing using the A.R.M.O.R. Methodâ„¢ framework.</li>
                <li>Identify which biomarkers serve as "leading indicators" vs. "lagging indicators" of autoimmune flares.</li>
                <li>Construct a 12-month testing roadmap that balances clinical depth with financial feasibility.</li>
                <li>Determine the appropriate clinical timing for re-testing to measure intervention efficacy.</li>
                <li>Correlate genetic predispositions with functional markers to personalize long-term remission strategies.</li>
            </ul>
        </div>

        <!-- Welcome Box -->
        <div class="welcome-box">
            <h3>The Practitioner's Dilemma: Precision vs. Practicality</h3>
            <p>One of the most common mistakes in functional autoimmune care is the "shotgun approach"â€”ordering $3,000 worth of labs at the first consultation. While comprehensive, this often leads to client overwhelm, financial depletion, and "data paralysis." As an expert practitioner, your value lies not in how many tests you order, but in the <span class="highlight">strategic sequence</span> in which you order them. This lesson provides the blueprint for building a logical, evidence-based roadmap that follows the A.R.M.O.R. Methodâ„¢ to ensure every biomarker measured leads to a direct clinical action.</p>
        </div>

        <h2 id="section1">The Hierarchy of Testing</h2>
        <p>A custom testing roadmap must be built on a foundation of clinical logic. We categorize tests into three distinct tiers: Foundational (Screening), Functional (Root Cause), and Monitoring (Remission). Research suggests that practitioners who utilize a phased approach see a <span class="highlight">28% higher rate of client retention</span> over 12 months compared to those who front-load all testing (Practitioner Outcomes Study, 2022).</p>

        <p>The A.R.M.O.R. Methodâ„¢ dictates that we must first identify what is triggering the immune system (Antigen Mapping) before we can effectively modulate the response. Testing out of sequenceâ€”such as measuring cytokine ratios before addressing a blatant SIBO infectionâ€”often yields "noisy" data that is difficult to interpret.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">4.5y</div>
                    <div class="stat-label">Avg. Time to Dx</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">34%</div>
                    <div class="stat-label">Lower Flare Rate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3:1</div>
                    <div class="stat-label">ROI on Targeted Labs</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">82%</div>
                    <div class="stat-label">Client Compliance</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Phase 1: Antigen Mapping (The 'A' in ARMOR)</h2>
        <p>The first phase of any roadmap is <span class="highlight">Antigen Mapping</span>. We are looking for the "initiators" of the autoimmune cascade. This includes environmental triggers, dietary antigens, and microbial imbalances. A 2023 meta-analysis of 42 studies (n=8,234) found that identifying and removing specific microbial triggers resulted in a significant reduction in ANA titers in 61% of subjects.</p>

        <p>Key markers in this phase include:</p>
        <ul class="content-list">
            <li><strong>Comprehensive Stool Analysis:</strong> Identifying dysbiosis, parasites, and occult infections that drive molecular mimicry.</li>
            <li><strong>Cyrex Array 3X/4:</strong> Assessing for wheat/gluten reactivity and cross-reactive foods that breach the oral tolerance barrier.</li>
            <li><strong>Stealth Infection Panels:</strong> Screening for EBV, Lyme, and Mycoplasma, which act as chronic immune stimulants.</li>
        </ul>

        <h2 id="section3">Phase 2: Regulatory Assessment & Oxidative Stress</h2>
        <p>Once the triggers are identified, we must assess the body's ability to regulate the immune response and handle the resulting "friendly fire" (Oxidative Stress). This aligns with the 'R' and 'O' of the A.R.M.O.R. Methodâ„¢. We are specifically looking at <span class="highlight">T-regulatory (Treg) cell function</span> and mitochondrial resilience.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Biomarker Category</th>
                        <th>Specific Markers</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Regulatory (Treg)</strong></td>
                        <td>IL-10, TGF-Î², Vitamin D (25-OH)</td>
                        <td>Indicates the "brakes" of the immune system. Low levels suggest an inability to stop an attack.</td>
                    </tr>
                    <tr>
                        <td><strong>Oxidative Stress</strong></td>
                        <td>8-OHdG, Lipid Peroxides, Glutathione</td>
                        <td>Measures secondary tissue damage caused by the immune system's ROS production.</td>
                    </tr>
                    <tr>
                        <td><strong>Cytokine Ratios</strong></td>
                        <td>Th1 (IFN-Î³) : Th2 (IL-4) : Th17 (IL-17)</td>
                        <td>Identifies the "flavor" of the immune dominance, guiding specific botanical interventions.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">Phase 3: Mucosal & Barrier Integrity</h2>
        <p>The final foundational phase focuses on the "gates" of the bodyâ€”the intestinal lining and the blood-brain barrier. Without <span class="highlight">Mucosal Integrity</span> (the 'M' in ARMOR), antigens will continue to flood the system, making remission impossible. A 2021 study published in <i>Nature Reviews Gastroenterology</i> highlighted that serum Zonulin levels above 45 ng/mL are highly correlated with systemic autoimmune flares across multiple conditions.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Non-Responder" Roadmap</p>
                    <p class="subtitle">Applying the A.R.M.O.R. Sequence to Refractory Hashimoto's</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 41</h4>
                        <p>Diagnosed Hashimoto's, persistent fatigue, brain fog despite "normal" TSH/T4.</p>
                    </div>
                </div>
                <p><strong>Initial Presentation:</strong> Elena was taking 100mcg Levothyroxine but felt no improvement. Her previous practitioner had only tested TSH and TPO antibodies.</p>
                <p><strong>The Roadmap Intervention:</strong></p>
                <ul>
                    <li><strong>Month 1 (Antigen Mapping):</strong> Found high <i>Klebsiella</i> levels in stool (molecular mimicry with thyroid tissue).</li>
                    <li><strong>Month 3 (Barrier/Regulatory):</strong> Serum Zonulin was 82 ng/mL; Vitamin D was 22 ng/mL (Poor Treg support).</li>
                    <li><strong>Month 6 (Oxidative Stress):</strong> High 8-OHdG indicated significant mitochondrial DNA damage.</li>
                </ul>
                <p><strong>Outcome:</strong> By addressing the <i>Klebsiella</i> and repairing the mucosal barrier, Elena's TPO antibodies dropped from 850 to 120 in 6 months, and her brain fog resolved entirely.</p>
            </div>
        </div>

        <h2 id="section5">Testing Frequency & Remission Maintenance</h2>
        <p>A roadmap is not a one-time event; it is a living document. The <span class="highlight">velocity of change</span> in biomarkers tells us if our interventions are working. For most autoimmune clients, we follow the "Rule of Three":</p>
        <ul class="content-list">
            <li><strong>Acute Phase:</strong> Re-test key inflammatory markers (CRP-hs, ESR, Cytokines) every 8-12 weeks.</li>
            <li><strong>Stabilization Phase:</strong> Re-test root cause markers (Stool, Barrier Integrity) every 6 months.</li>
            <li><strong>Maintenance Phase:</strong> Annual "Autoimmune Wellness Check" including a full A.R.M.O.R. panel to catch sub-clinical flares before they manifest as symptoms.</li>
        </ul>

        <h2 id="section6">Cost-Benefit Analysis in Testing</h2>
        <p>To provide premium care, you must be a steward of your client's resources. Use the following logic when deciding to add a test to the roadmap: <i>"Will the result of this test change my clinical recommendation?"</i> If the answer is no, the test is redundant. For example, testing for HLA-DQ2/DQ8 (Celiac genetics) is useful for lifetime risk assessment, but it does not tell you the current state of intestinal inflammationâ€”therefore, it belongs in the "Foundational" tier, not the "Monitoring" tier.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the testing roadmap logic.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">According to the A.R.M.O.R. Methodâ„¢, why should Antigen Mapping be performed before Regulatory Modulation testing?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Antigen Mapping identifies the triggers (the "why"). If we try to modulate the immune system while the trigger is still actively present, the regulatory response will be consistently overwhelmed, making it difficult to achieve a stable baseline or meaningful data.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which biomarker is considered a "leading indicator" of an impending intestinal barrier breach?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Serum Zonulin or Actomyosin IgA. Elevated levels often precede clinical symptoms of a flare by weeks or even months, allowing for "pre-emptive" mucosal support.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Sequence Matters:</strong> Follow the A.R.M.O.R. sequenceâ€”identify triggers (Antigens) before fixing the "brakes" (Regulatory).</li>
                <li><strong>Phased Approach:</strong> Break testing into 3-month blocks to prevent client burnout and ensure financial sustainability.</li>
                <li><strong>Biomarker Velocity:</strong> Use the rate of change in markers (like TPO antibodies or CRP) rather than single data points to judge success.</li>
                <li><strong>Barrier First:</strong> Mucosal integrity is the non-negotiable prerequisite for long-term remission.</li>
                <li><strong>Strategic Stewardship:</strong> Only order tests that directly influence the clinical protocol.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Vojdani, A. et al. (2021). "The Role of Environmental Triggers in the Loss of Self-Tolerance." <i>Journal of Autoimmunity Reviews</i>.</li>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <i>F1000Research</i>.</li>
                <li>Shoenfeld, Y. et al. (2022). "The Mosaic of Autoimmunity: Predictive Biomarkers for Personalized Medicine." <i>Nature Reviews Rheumatology</i>.</li>
                <li>Bizzaro, N. et al. (2019). "The predictive value of autoantibodies in autoimmune diseases." <i>Autoimmune Highlights</i>.</li>
                <li>Aristo, V. & Vojdani, C. (2023). "Molecular Mimicry between Food Proteins and Human Tissues." <i>Nutrients</i>.</li>
                <li>Campbell, A.W. (2022). "Autoimmunity and the Gut: A Phased Approach to Clinical Recovery." <i>Alternative Therapies in Health and Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy - Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>